(CVGI) Commercial Vehicle - Overview
Sector: Consumer Cyclical | Industry: Auto Parts | Exchange: NASDAQ (USA) | Market Cap: 175m USD | Total Return: 290.2% in 12m
Avg Turnover: 2.20M
Qual. Beats: 0
Rev. Trend: -97.2%
Qual. Beats: 0
Warnings
Interest Coverage Ratio 0.3 is critical
Tailwinds
Supp Ema20, Rs Leader, Idiosyncratic Leader, Tailwind, Pullback 52w, Confidence
Commercial Vehicle Group Inc (CVGI) is a global supplier of systems and components for the commercial and electric vehicle markets. The company operates through three primary segments: Global Seating, Global Electrical Systems, and Trim Systems and Components. Its product portfolio includes heavy-duty seats, high and low voltage cable assemblies, and molded plastic interior components sold under established brands such as National Seating and Bostrom Seating.
The business model relies on deep integration with Original Equipment Manufacturers (OEMs) in the heavy-duty truck, construction, and agricultural sectors. As a Tier 1 supplier, CVGI is sensitive to cyclical fluctuations in global freight volumes and infrastructure spending, which directly impact the production schedules of its primary customers. The company has recently expanded its electrical segment to address the increasing demand for wire harnesses in electric vehicle (EV) architectures.
To better understand the companys valuation and growth metrics, you may want to review further data on ValueRay. Headquartered in Ohio, CVGI maintains a manufacturing and distribution footprint across North America, Europe, and the Asia-Pacific region to support its diversified industrial client base.
- Class 8 truck production volumes drive Global Seating segment revenue
- Raw material costs and labor inflation impact consolidated operating margins
- Electric vehicle adoption accelerates demand for high-voltage cable and harness assemblies
- Diversification into construction and agriculture equipment reduces heavy-truck cyclicality risk
| Net Income: -17.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 12.37 > 1.0 |
| NWC/Revenue: 22.58% < 20% (prev 22.17%; Δ 0.41% < -1%) |
| CFO/TA 0.07 > 3% & CFO 27.9m > Net Income -17.6m |
| Net Debt (81.9m) to EBITDA (19.2m): 4.26 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.5m) vs 12m ago 5.40% < -2% |
| Gross Margin: 11.00% > 18% (prev 0.11%; Δ 1.09k% > 0.5%) |
| Asset Turnover: 156.3% > 50% (prev 166.4%; Δ -10.04% > 0%) |
| Interest Coverage Ratio: 0.30 > 6 (EBITDA TTM 19.2m / Interest Expense TTM 14.6m) |
| A: 0.36 (Total Current Assets 276.7m - Total Current Liabilities 129.8m) / Total Assets 412.5m |
| B: -0.23 (Retained Earnings -95.9m / Total Assets 412.5m) |
| C: 0.01 (EBIT TTM 4.43m / Avg Total Assets 416.2m) |
| D: -0.45 (Book Value of Equity -125.6m / Total Liabilities 281.6m) |
| Altman-Z'' = 1.18 = BB |
| DSRI: 0.91 (Receivables 100.8m/119.5m, Revenue 650.7m/698.5m) |
| GMI: 0.99 (GM 11.00% / 10.85%) |
| AQI: 3.33 (AQ_t 0.18 / AQ_t-1 0.05) |
| SGI: 0.93 (Revenue 650.7m / 698.5m) |
| TATA: -0.11 (NI -17.6m - CFO 27.9m) / TA 412.5m) |
| Beneish M = -1.90 (Cap -4..+1) = B |
As of May 30, 2026, the stock is trading at USD 5.15 with a total of 243,725 shares traded.
Over the past week, the price has changed by +7.07%,
over one month by +29.72%,
over three months by +201.17% and
over the past year by +290.15%.
Commercial Vehicle has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy CVGI.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 7.2 | 39.2% |
P/E Forward = 13.5318
P/S = 0.2686
P/B = 1.2779
P/EG = 0.2696
Revenue TTM = 650.7m USD
EBIT TTM = 4.43m USD
EBITDA TTM = 19.2m USD
Long Term Debt = 89.7m USD (from longTermDebt, last quarter)
Short Term Debt = 12.3m USD (from shortTermDebt, last quarter)
Debt = 110.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 8.50m
Net Debt = 81.9m USD (calculated: Debt 110.6m - CCE 28.7m)
Enterprise Value = 256.7m USD (174.8m + Debt 110.6m - CCE 28.7m)
Interest Coverage Ratio = 0.30 (Ebit TTM 4.43m / Interest Expense TTM 14.6m)
EV/FCF = 13.95x (Enterprise Value 256.7m / FCF TTM 18.4m)
FCF Yield = 7.17% (FCF TTM 18.4m / Enterprise Value 256.7m)
FCF Margin = 2.83% (FCF TTM 18.4m / Revenue TTM 650.7m)
Net Margin = -2.70% (Net Income TTM -17.6m / Revenue TTM 650.7m)
Gross Margin = 11.00% ((Revenue TTM 650.7m - Cost of Revenue TTM 579.2m) / Revenue TTM)
Gross Margin QoQ = 11.55% (prev 9.71%)
Tobins Q-Ratio = 0.62 (Enterprise Value 256.7m / Total Assets 412.5m)
Interest Expense / Debt = 13.22% (Interest Expense 14.6m / Debt 110.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = 3.50m (EBIT 4.43m * (1 - 21.00%))
Current Ratio = 2.13 (Total Current Assets 276.7m / Total Current Liabilities 129.8m)
Debt / Equity = 0.84 (Debt 110.6m / totalStockholderEquity, last quarter 131.0m)
Debt / EBITDA = 4.26 (Net Debt 81.9m / EBITDA 19.2m)
Debt / FCF = 4.45 (Net Debt 81.9m / FCF TTM 18.4m)
Total Stockholder Equity = 135.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.22% (Net Income -17.6m / Total Assets 412.5m)
RoE = -7.58% (Net Income TTM -17.6m / Total Stockholder Equity 231.8m)
RoCE = 1.38% (EBIT 4.43m / Capital Employed (Equity 231.8m + L.T.Debt 89.7m))
RoIC = 1.31% (NOPAT 3.50m / Invested Capital 266.5m)
WACC = 11.91% (E(174.8m)/V(285.4m) * Re(12.83%) + D(110.6m)/V(285.4m) * Rd(13.22%) * (1-Tc(0.21)))
Discount Rate = 12.83% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 82.22 | Cagr: 2.70%
[DCF] Terminal Value 64.05% ; FCFF base≈18.4m ; Y1≈18.5m ; Y5≈19.6m
[DCF] Fair Price = 3.20 (EV 189.7m - Net Debt 81.9m = Equity 107.9m / Shares 33.7m; r=11.91% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.81 | # QB: 0
Revenue Correlation: -97.22 | Revenue CAGR: -15.82% | SUE: 0.44 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.05 | Chg30d=+48.11% | Revisions=+14% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.01 | Chg30d=N/A | Revisions=+20% | Analysts=3
EPS current Year (2026-12-31): EPS=-0.10 | Chg30d=+46.44% | Revisions=+43% | GrowthEPS=+79.2% | GrowthRev=+4.9%
EPS next Year (2027-12-31): EPS=0.10 | Chg30d=-41.39% | Revisions=N/A | GrowthEPS=+196.7% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +43%